ArriVent BioPharma, Inc. 10-K filing
Filed 2026-03-05 · Report date 2025-12-31 · 2025 FY
Filing metadata
- Accession number
- 0001104659-26-024127
- Form type
- 10-K
- CIK
- 0001868279
- Primary document
- https://www.sec.gov/Archives/edgar/data/1868279/000110465926024127/avbp-20251231x10k.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for ArriVent BioPharma, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-177.5M | - | - |
| Net Income | $-166.3M | - | - |
| Eps Basic | -4.32 | - | - |
| Eps Diluted | -4.32 | - | - |
| Cash And Equivalents | $45.5M | - | - |
| Total Assets | $333.2M | - | - |
| Total Liabilities | $25.9M | - | - |
| Shareholders Equity | $307.2M | - | - |
| Operating Cash Flow | $-160.6M | - | - |